Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model

por Torkildsen, Gail, Narvekar, Abhijit, Bergmann, Mark
Publicado 2015

Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%

por Bergmann, Mark T, Williams, Jon I, Gomes, Paul J
Publicado 2014

Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis

por McLaurin, Eugene, Bergmann, Mark, Narvekar, Abhijit, Adewale, Adeniyi, Gomes, Paul, Torkildsen, Gail
Publicado 2017

Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca

por Sheppard, John, Bergmann, Mark, Schechter, Barry A, Luchs, Jodi, Ogundele, Abayomi, Karpecki, Paul
Publicado 2021